Form 8-K - Current report:
SEC Accession No. 0001171843-26-002720
Filing Date
2026-04-27
Accepted
2026-04-27 07:30:23
Documents
30
Period of Report
2026-04-27
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_042526.htm   iXBRL 8-K 27121
2 PRESS RELEASE exh_991.htm EX-99.1 15378
3 EXHIBIT 99.2 exh_992.htm EX-99.2 21106
4 exh992_01.jpg GRAPHIC 185412
5 exh992_02.jpg GRAPHIC 252285
6 exh992_03.jpg GRAPHIC 166649
7 exh992_04.jpg GRAPHIC 151851
8 exh992_05.jpg GRAPHIC 126193
9 exh992_06.jpg GRAPHIC 206995
10 exh992_07.jpg GRAPHIC 103406
11 exh992_08.jpg GRAPHIC 120541
12 exh992_09.jpg GRAPHIC 114448
13 exh992_10.jpg GRAPHIC 98321
14 exh992_11.jpg GRAPHIC 103928
15 exh992_12.jpg GRAPHIC 103602
16 exh992_13.jpg GRAPHIC 194441
17 exh992_14.jpg GRAPHIC 187426
18 exh992_15.jpg GRAPHIC 164033
19 exh992_16.jpg GRAPHIC 80784
  Complete submission text file 0001171843-26-002720.txt   3527465

Data Files

Seq Description Document Type Size
20 XBRL SCHEMA FILE gnw-20250101.xsd EX-101.SCH 3402
21 XBRL DEFINITION FILE gnw-20250101_def.xml EX-101.DEF 26066
22 XBRL LABEL FILE gnw-20250101_lab.xml EX-101.LAB 35956
23 XBRL PRESENTATION FILE gnw-20250101_pre.xml EX-101.PRE 24702
33 EXTRACTED XBRL INSTANCE DOCUMENT f8k_042526_htm.xml XML 2849
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Filer) CIK: 0001738021 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39696 | Film No.: 26896533
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)